Greehey CCRI Seminar Series, Spring ’23: Roger Greenberg, M.D., Ph.D. – Penn University

The Greenberg lab is interested in understanding how chromatin responses to DNA damage impact genome integrity, cancer susceptibility, and response to anti-cancer therapy. Our basic findings have led to the identification of three new breast cancer susceptibility genes, a human syndrome associated with biallelic BRCA1 mutations, and insights into mechanisms by which chromatin responses affect response to targeted therapies.

Learn More About Dr. Greenberg